Varex Imaging (VREX) Expected to Announce Earnings on Thursday

Varex Imaging (NASDAQ:VREX) is expected to be issuing its Q1 2026 results before the market opens on Thursday, February 5th. Analysts expect the company to announce earnings of $0.14 per share and revenue of $207.8250 million for the quarter. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. Interested persons may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Tuesday, February 10, 2026 at 5:00 PM ET.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Tuesday, November 18th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.19. The business had revenue of $228.90 million for the quarter, compared to analyst estimates of $219.26 million. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Trading Down 0.7%

Shares of VREX stock opened at $13.98 on Thursday. The firm has a 50-day moving average price of $12.34 and a 200 day moving average price of $11.32. Varex Imaging has a twelve month low of $6.76 and a twelve month high of $15.46. The company has a market capitalization of $586.04 million, a price-to-earnings ratio of -8.22 and a beta of 0.86. The company has a current ratio of 3.43, a quick ratio of 1.83 and a debt-to-equity ratio of 0.75.

Hedge Funds Weigh In On Varex Imaging

A number of hedge funds have recently made changes to their positions in VREX. Millennium Management LLC grew its stake in shares of Varex Imaging by 119.8% during the 3rd quarter. Millennium Management LLC now owns 913,169 shares of the company’s stock valued at $11,323,000 after buying an additional 497,650 shares during the period. Qube Research & Technologies Ltd boosted its holdings in Varex Imaging by 2,514.9% in the second quarter. Qube Research & Technologies Ltd now owns 318,127 shares of the company’s stock valued at $2,758,000 after acquiring an additional 305,961 shares during the last quarter. Deerfield Management Company L.P. purchased a new stake in Varex Imaging during the third quarter valued at about $3,537,000. JPMorgan Chase & Co. increased its stake in Varex Imaging by 381.8% during the third quarter. JPMorgan Chase & Co. now owns 284,227 shares of the company’s stock worth $3,524,000 after acquiring an additional 225,238 shares during the last quarter. Finally, Federated Hermes Inc. purchased a new position in shares of Varex Imaging in the 2nd quarter worth about $1,946,000.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on VREX. B. Riley reiterated a “buy” rating and set a $16.00 price target on shares of Varex Imaging in a report on Wednesday, November 19th. Oppenheimer lowered their target price on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a report on Monday, December 29th. Finally, Wall Street Zen upgraded Varex Imaging from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 22nd. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $17.00.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.